The Agilent team delivered another excellent quarter to close out an outstanding record-setting 2021.
At $6.32 billion for fiscal 2021, revenues are almost $1 billion higher than last year.
Full year core growth is up 15% on top of growing 1% last year.
The strength is broad-based for the three business units, all growing more than 10% core for the year.
Our full year operating margin was up 200 basis points.
Earnings per share are $4.34 or up 32%.
This is our formula for delivering solid financial results, outstanding shareholder returns and continued strong growth.
The Small Molecule segment delivered mid-teens growth, while Large Molecule grew 30%.
